0001415889-23-013038.txt : 20230906
0001415889-23-013038.hdr.sgml : 20230906
20230906190349
ACCESSION NUMBER: 0001415889-23-013038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230901
FILED AS OF DATE: 20230906
DATE AS OF CHANGE: 20230906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Paolini John F.
CENTRAL INDEX KEY: 0001741533
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38492
FILM NUMBER: 231240611
MAIL ADDRESS:
STREET 1: C/O KINIKSA PHARMACEUTICALS, LTD.
STREET 2: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
FORMER NAME:
FORMER CONFORMED NAME: Paolini John
DATE OF NAME CHANGE: 20180522
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kiniksa Pharmaceuticals, Ltd.
CENTRAL INDEX KEY: 0001730430
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: D0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
BUSINESS PHONE: 7814399100
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
form4-09062023_110943.xml
X0508
4
2023-09-01
0001730430
Kiniksa Pharmaceuticals, Ltd.
KNSA
0001741533
Paolini John F.
C/O KINIKSA PHARMACEUTICALS, LTD.
CLARENDON HOUSE 2 CHURCH STREET
HAMILTON
D0
HM 11
BERMUDA
false
true
false
false
CHIEF MEDICAL OFFICER
1
Class A Common Share
2023-09-01
4
M
0
2498
A
44408
D
Class A Common Share
2023-09-01
4
F
0
734
17.76
D
43674
D
Class A Common Share
2023-09-02
4
M
0
1725
A
45399
D
Class A Common Share
2023-09-02
4
F
0
507
17.76
D
44892
D
Class A Common Share
2023-09-05
4
M
0
400
1.86
A
45292
D
Class A Common Share
2023-09-05
4
S
0
400
17.53
D
44892
D
Restricted Share Unit
2023-09-01
4
M
0
2498
0
D
Class A Common Share
2498
7492
D
Restricted Share Unit
2023-09-01
4
A
0
6496
0
A
Class A Common Share
6496
6496
D
Share Option
17.76
2023-09-01
4
A
0
38974
0
A
2033-08-31
Class A Common Share
38974
38974
D
Restricted Share Unit
2023-09-02
4
M
0
1725
0
D
Class A Common Share
1725
3450
D
Share Option
1.86
2023-09-05
4
M
0
400
0
D
2026-09-13
Class A Common Share
400
139817
D
Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer.
This transaction was effected pursuant to a Rule 10b5-1 plan executed by the reporting person on May 5, 2023.
This transaction was executed in multiple trades through a broker-dealer at prices ranging from $17.50 to $17.56. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2022.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 1, 2023.
The option vests and becomes exercisable as to 25% of the total grant on the first anniversary of the vesting commencement date and vests in 36 equal monthly installments thereafter. The vesting commencement date is September 1, 2023.
The RSUs vest over a four-year period, with 25% of the RSUs vesting on each yearly anniversary of the date of the grant, September 2, 2021.
The option is fully vested and exercisable.
/s/ Madelyn Zeylikman, Attorney-in-Fact
2023-09-06